**5. Acknowledgment**

We thank the Ligue Nationale Contre le Cancer (Comité du Nord) and the Institut pour la Recherche sur le Cancer de Lille (IRCL) for grants, as well as the Université de Lille 2, the Conseil Régional Nord/Pas-de-Calais and the IRCL for a PhD fellowship to Gaëlle Lenglet.

### **6. References**


on the importance of DNA destabilization on DNA repair processes and induced-cytotoxic activities illustrate the need for an accurate examination of precise mode of binding /bonding to DNA of potential anti-cancer drugs in terms of 3D structure/activity relationships and to clearly evaluate the cellular consequences (cytotoxicity, DNA repair processes).

We thank the Ligue Nationale Contre le Cancer (Comité du Nord) and the Institut pour la Recherche sur le Cancer de Lille (IRCL) for grants, as well as the Université de Lille 2, the Conseil Régional Nord/Pas-de-Calais and the IRCL for a PhD fellowship to Gaëlle Lenglet.

Ahmad, R.; Naoui, M.; Neault, J.F.; Diamantoglou, S. & Tajmir-Riahi, H.A. (1996). An FTIR

Ahmad, S. (2010). Platinum-DNA interactions and subsequent cellular processes controlling

Arita, K.; Ariyoshi, M.; Tochio, H.; Nakamura, Y. & Shirakawa, M. (2008). Recognition of

*Nature*, Vol.455, No.7214, (October 2008), pp. 818-21, ISSN 0028-0836 Aune, G.J.; Takagi, K.; Sordet, O.; Guirouilh-Barbat, J.; Antony, S.; Bohr, V.A. & Pommier, Y.

spectroscopic study of calf-thymus DNA complexation with Al(III) and Ga(III) cations. *Journal of Biomolecular Structure & Dynamics*, Vol.13, No.5, (April 1996), pp.

sensitivity to anticancer platinum complexes. *Chemistry & Biodiversity*, Vol.7, No.3,

hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism.

(2008). Von Hippel-Lindau-coupled and transcription-coupled nucleotide excision repair-dependent degradation of RNA polymerase II in response to trabectedin. *Clinical Cancer Research*, Vol.14, No.20, (October 2008), pp. 6449-55, ISSN 1078-0432 Basu, A.K.; Hanrahan, C.J.; Malia, S.A.; Kumar, S.; Bizanek, R. & Tomasz, M. (1993). Effect of

site-specifically located mitomycin C-DNA monoadducts on in vitro DNA synthesis by DNA polymerases. *Biochemistry,* Vol.32, No.18, (May 1993), pp. 4708-

glycosylase indicates an active mechanism of base flipping. *Nucleic Acids Research*,

intrastrand cross-links of the antitumor drug *cis-*diamminedichloroplatinum(II).

specific transcriptional regulatory regions. *Journal of Molecular Biology*, Vol.255,

Basu, A. & Krishnamurthy, S. (2010). Cellular responses to Cisplatin-induced DNA damage.

Bellamy, S.R.; Krusong, K. & Baldwin, G.S. (2007). A rapid reaction analysis of uracil DNA

Bellon, S.F.; Coleman, J.H. & Lippard, S.J. (1991). DNA unwinding produced by site-specific

Bera, A.; Roche, A.C. & Nandi, P.K. (2007). Bending and unwinding of nucleic acid by prion protein. *Biochemistry*, Vol.46, No.5, (February 2007), pp. 1320-8, ISSN 0006-2960

*Biochemistry*, Vol.30, No.32, (August 1991), pp. 8026-35, ISSN 0006-2960 Benham, C.J. (1996). Duplex destabilization in superhelical DNA is predicted to occur at

*Journal of Nucleic Acids*, (August 2010), pp. 201367, ISSN 2036-7996

Vol.35, No.5, (February 2007), pp. 1478-87, ISSN 0305-1048

No.3, (January 1996), pp. 425-34, ISSN 0022-2836

**5. Acknowledgment** 

795-802, ISSN 0739-1102

18, ISSN 0006-2960

(March 2010), pp. 543-66, ISSN 1612-1880

**6. References** 


DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair 115

David-Cordonnier, M.-H.; Payet, D.; D'Halluin, J.-C.; Waring, M.J.; Travers, A.A. & Bailly, C.

David-Cordonnier, M.-H.; Hamdane, M.; Bailly, C.; D'Halluin, J.-C. (1998). The DNA

Depauw, S.; Gaslonde, T.; Léonce, S.; Kraus-Berthier, L.; Laine, W.; Lenglet, G.; Chiaroni, A.;

Ding, S.; Shapiro, R.; Geacintov, N.E. & Broyde, S. (2005). Equilenin-derived DNA adducts

Ding, S.; Shapiro, R.; Geacintov, N.E. & Broyde, S. (2007). 4-hydroxyequilenin-adenine

Dornberger, U.; Leijon, M. & Fritzsche, H. (1999). High base pair opening rates in tracts of

Dronkert, M.L. & Kanaar, R. (2001). Repair of DNA interstrand cross-links. *Mutation Research*, Vol.486, No.4, (September 2001), pp. 217–47, ISSN 0027-5107 Embrechts, J.; Lemiere, F.; Van Dongen, W.; Esmans, E.L.; Buytaert, P.; Van Marck, E.;

Everhard, S.; Kaloshi, G.; Crinière, E.; Benouaich-Amiel, A.; Lejeune, J.; Marie, Y.; Sanson,

*Biochemistry*, Vol.41, No. 31, (August 2002), pp. 9911-20, ISSN 0006-2960 David-Cordonnier, M.-H.; Laine, W.; Lansiaux, A.; Rosu, F.; Colson, P.; de Pauw, E.; Michel,

(January 2005), pp. 71-80, ISSN 1535-7163

2009), pp. 1172-85, ISSN 0026-895X

6957-62, ISSN 0021-9258

2003), pp. 482–91, ISSN

Vol.27, No.11, (June 1999), pp. 2265-70, ISSN 0305-1048

Vol.37, No.17, (April 1998), pp. 6065-76, ISSN 0006-2960

No.44, (November 2005), pp. 14565-76, ISSN 0006-2960

Vol.46, No.1, (January 2007), pp. 182-91, ISSN 0006-2960

novel potent antitumor compound derived from the plant alkaloid acronycine.

S.; Tillequin, F.; Koch, M.; Hickman, J.A.; Pierré, A. & Bailly, C. (2005). Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism. *Molecular Cancer Therapeutics*, Vol.4, No.1,

(1999). The DNA-binding domain of human c-Abl tyrosine kinase promotes the interaction of a HMG chromosomal protein with DNA. *Nucleic Acids Research*,

binding domain of the human c-Abl tyrosine kinase preferentially binds to DNA sequences containing an AAC-motif and to distorted DNA structures. *Biochemistry*,

Pfeiffer, B.; Bailly, C.; Michel, S.; Tillequin, F.; Pierré, A. & David-Cordonnier, M.-H. (2009). Influence of the stereoisomeric position of the reactive acetate groups of the benzo[*b*]acronycine derivative S23906-1 on its DNA alkylation, helix opening, cytotoxic and anti-tumor activities. *Molecular Pharmacoly*, Vol.76, No.6, (December

to cytosine in DNA duplexes: structures and thermodynamics. *Biochemistry*, Vol.44,

lesions in DNA duplexes: stereochemistry, damage site, and structure. *Biochemistry*,

GC base pairs. *Journal of Biological Chemistry*, Vol.274, No.11, (March 1999), pp.

Kockx, M. & Makar, A. (2003). Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. *Journal of the American Society of Mass Spectrometry*, Vol.14, No.5 (May

M.; Kujas, M.; Mokhtari, K.; Hoang-Xuan, K.; Delattre, J.Y. & Thillet, J. (2006). MGMT methylation: a marker of response to temozolomide in low-grade gliomas. *Annals of neurology* , Vol.60, No.6, (December 2006), pp 740-3, ISSN 0364-5134

the binding of the equine estrogen metabolite 4-OHEN to dC and dA adducts in vitro. *Proceedings of the 97th Annual Meeting of the American Association for Cancer Research, 2006 Apr 1-5, Washington, DC. Philadelphia (PA): AACR*, Vol.47, Abstract #5255.


Choi, C.H.; Kalosakas, G.; Rasmussen, K.O.; Hiromura, M.; Bishop, A.R. & Usheva, A.

Chvalova, K.; Sari, M.A. Bombard, S. & Kozelka, J. (2008). LEF-1 recognition of platinated

Clement, F.C.; Camenisch, U.; Fei, J.; Kaczmarek, N.; Mathieu, N. & Naegeli, H. (2010).

Cosman, M.; De los Santos, C.; Fiala, R.; Hingerty, B.E.; Ibanez, V.; Luna, E.; Harvey, R.;

Couvé-Privat, S.; Macé, G.; Rosselli, F & Saparbaev, M.K. (2007). Psoralen-induced DNA

*Acids Research*, Vol.35, No. 18, (March 2009), pp. 5672–5682, ISSN 0305-1048 Damia, G.; Silvestri, S.; Carrassa, L.; Filiberti, L.; Faircloth, G.T.; Liberi, G.; Foiani, M. &

Darzynkiewicz, Z.; Evenson, D.; Kapuscinski, J. & Melamed, M.R. (1983). Denaturation of

D'Atri, S.; Tentori, L.; Lacal, P.M.; Graziani, G.; Pagani, E.; Benincasa, E.; Zambruno, G.;

David-Cordonnier, M.-H.; Gajate, C.; Olmea, O.; Laine, W.; de la Iglesia-Vicente, J.; Perez, C.;

David, A.; Bleimling, N.; Beuck, C.; Lehn, J.M.; Weinhold, E.; Teulade-Fichou, M.P. (2003).

David-Cordonnier, M.-H.; Laine, W.; Lansiaux, A.; Kouach, M.; Briand, G.; Pierré, A.;

*Research*, Vol.32, No.4, (March 2004), pp. 1584-90, ISSN 0305-1048

(March 2010), pp. 21-8, ISSN 0027-5107

Vol.92, No.4, (May 2001), pp. 583-8, ISSN 1097-0215

1998), pp. 334–341, ISSN 0026-895X

Vol.148, No.1, (October 1983), pp. 31-46, ISSN 0014-4827

Vol.4, No.12, (December 2003), pp. 1326-31, ISSN 1439-4227

#5255.

8257

2960

the binding of the equine estrogen metabolite 4-OHEN to dC and dA adducts in vitro. *Proceedings of the 97th Annual Meeting of the American Association for Cancer Research, 2006 Apr 1-5, Washington, DC. Philadelphia (PA): AACR*, Vol.47, Abstract

(2004). DNA dynamically directs its own transcription initiation. *Nucleic Acids* 

GG sequences within double-stranded DNA. Influence of flanking bases. J*ournal of Biological Inorganic Chemistry*, Vol.102, No.2, (February 2008), pp. 242-50, ISSN 0949-

Dynamic two-stage mechanism of versatile DNA damage recognition by xeroderma pigmentosum group C protein. *Mutation Research*, Vol.685, No.1-2,

Geacintov, N.E.; Broyde, S. & Patel, D.J. (1993). Solution conformation of the (+)-*cisanti-*[BP]dG adduct in a DNA duplex: intercalation of the covalently attached benzo[*a*]pyrenyl ring into the helix and displacement of the modified deoxyguanosine. *Biochemistry*, Vol.32, No.16, (April 1993), pp. 4145–55, ISSN 0006-

adducts are substrates for the base excision repair pathway in human cells. *Nucleic* 

D'Incalci, M. (2001). Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways. *International Journal of Cancer*,

RNA and DNA in situ induced by acridine orange. *Experimental Cell Research*,

Bonmassar, E. & Jiricny, J. (1998). Involvement of the mismatch repair system in temozolomide-induced apoptosis. *Molecular Pharmacology*, Vol.54, No.2, (August

Cuevas, C.; Otero, G.; Bailly, C. & Mollinedo F. (2005). DNA and non-DNA targets in the mechanism of action of the antitumor drug Yondelis™ (trabectedin, ET-743). *Chemistry and Biology*, Vol.12, No.11, (November 2005), pp. 1201-10, ISSN 1074-5521

DNA mismatch-specific base flipping by a bisacridine macrocycle. *Chembiochem*,

Hickman, J.A. & Bailly, C. (2002). Alkylation of guanine in DNA by S23906-1, a

novel potent antitumor compound derived from the plant alkaloid acronycine. *Biochemistry*, Vol.41, No. 31, (August 2002), pp. 9911-20, ISSN 0006-2960


DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair 117

Herrick, G. & Alberts, B. (1976). Nucleic acid helix-coil transitions mediated by helix-

Hornby, D.P. & Ford, G.C. (1998). Protein-mediated base flipping. *Current Opinion in* 

Huang, J.C.; Zamble, D.B.; Reardon, J.T.; Lippard, S.J. & Sancar, A. (1994). HMG-domain

*Sciences USA*, Vol.91, No.22, (October 1994), pp. 10394-8, ISSN 0027-8424 Hurley, L.H. & Zewail-Foote, M. (2001). The antitumor agent ecteinascidin 743:

*Experimental Medicine and Biology*, Vol.500, pp. 289-99, ISSN 0065-2598 Jia, L.; Kropachev, K.; Ding, S.; Van Houten, B.; Geacintov, N.E. & Broyde, S. (2009).

Jin, S.; Gorfajn, B.; Faircloth, G. & Scotto, K.W. (2000). Ecteinascidin 743; a transcription-

Kapuscinski, J. & Darzynkiewicz, Z. (1983). Increased accessibility of bases in DNA upon

Kapuscinski, J. & Darzynkiewicz, Z. (1984). Denaturation of nucleic acids induced by

Karpel, R.L & Burchard, A.C. (1981). A basic isozyme of yeast glyceraldehyde-3-phosphate

Kasparkova, J.; Marini, V.; Bursova, V. & Brabec, V. (2008a). Biophysical studies on the

Kasparkova, J.; Vojtiskova, M.; Natile, G. & Brabec, V. (2008b). Unique properties of DNA

*Biophysica Acta*, Vol.654, No.2, (July 1981), pp. 256-67, ISSN 0006-3002 Kaspárková, J.; Nováková, O.; Vrána, O.; Farrell, N. & Brabec, V. (1999). Effect of geometric

No.9, (November 2008), pp. 4361-71, ISSN 0006-3495

*Biotechnology*, Vol.9, No.4, (August 1998), pp. 354-8, ISSN 0958-1669

(April 1976), pp. 2133-41, ISSN 0021-9258

(September 2009), pp. 8948-57, ISSN 0006-2960

2010), pp. 73-9, ISSN 0304-3835

pp. 7555-68, ISSN 0305-1048

1984), pp. 1485-99, ISSN 0739-1102

unwinding proteins from calf thymus. *Journal of Biological Chemistry*, Vol.251, No.7,

proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease. *Proceedings of the National Academy of* 

characterization of its covalent DNA adducts and chemical stability. *Advances in* 

Exploring damage recognition models in prokaryotic nucleotide excision repair with a benzo[*a*]pyrene-derived lesion in UvrB. *Biochemistry*, Vol.48, No.38,

targeted chemotherapeutic that inhibits MDR1 activation. *Proceedings of the National Academy of Sciences USA*, Vol.97, No.12, (June 2000), pp. 6775-9, ISSN 0027-8424 Kachnic, L.A.; Li. L; Fournier. L & Willers. H. (2010) Fanconi anemia pathway heterogeneity

revealed by cisplatin and oxaliplatin treatments. *Cancer Letters*, Vol.292, No.1, (June

binding of acridine orange. *Nucleic Acids Research*, Vol.11, No.21, (November 1983),

intercalating agents. Biochemical and biophysical properties of acridine orange-DNA complexes. *Journal of Biomolecular Structure & Dynamics*, Vol.1, No.6, (June

dehydrogenase with nucleic acid helix-destabilizing activity. *Biochimica and* 

isomerism in dinuclear platinum antitumor complexes on DNA interstrand crosslinking. *Biochemistry*, Vol.38, No.34, (August 1999), pp. 10997-1005, ISSN 0006-2960

stability of DNA intrastrand cross-links of transplatin. *Biophysical Journal*, Vol.95,

interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand. *Chemistry*, Vol.14, No.4, (January 2008), pp. 1330-41, ISSN 1521-3765 Kolbanovskiy, A.; Kuzmin, V.; Shastry, A.; Kolbanovskaya, M.; Chen, D.; Chang, M.; Bolton,

J.L. & Geacintov, N.E. (2005). Base selectivity and effects of sequence and DNA secondary structure on the formation of covalent adducts derived from the equine


Fishel, M.L.; He, Y.; Smith, M.L.; Kelley, M.R. (2008). Manipulation of base excision repair to

Fourrier, L.; Brooks, P. & Malinge, J.M. (2003). Binding discrimination of MutS to a set of

Fridman, A.S.; Brabec, V.; Haroutiunian, S.G.; Wartell, R.M. & Lando, D.Y. (2003). Melting of

Friedman, D.; Hu, Z.; Kolb, E.A.; Gorfajn, B. & Scotto, K.W. (2002). Ecteinascidin-743 inhibits

Fukushima, T.; Takeshima, H. & Kataoka, H. (2009). Anti-glioma Therapy with

García-Nieto, R.; Manzanares, I.; Cuevas, C. & Gago, F. (2000). Increased DNA binding

Guilbaud, N.; Kraus-Berthier, L.; Meyer-Losic, F.; Malivet, V.; Chacun, C.; Jan, M.; Tillequin,

Hägerlöf, M.; Papsai, P.; Chow, C.S. & Elmroth, S.K. (2006). More pronounced salt

Hartinger, C.G.; Jakupec, M.A.; Zorbas-Seifried, S.; Groessl, M.; Egger, A.; Berger, W.;

Harvey, S.C. (1983). DNA structural dynamics: longitudinal breathing as a possible

Herrero, A.B.; Martín-Castellanos, C.; Marco, E.; Gago, F. & Moreno, S. (2006). Cross-talk

*Pharmacology*, Vol.74, No.1, (July 2008), pp 173-83, ISSN 0026-895X

Vol.278, No.23, (June 2003), pp. 21267-75, ISSN 1044-0305

Vol.29, No.11, (November 2009), pp 4845-54, ISSN 0250-7005

pp. 533-45, ISSN 0739-1102

ISSN 0022-2623

80, ISSN 1078-0432

ISSN 1612-1880

pp. 4867-78, ISSN 0305-1048

(August 2006), pp. 8155-62, ISSN 0008-5472

8257

2002), pp. 3377-81, ISSN 0008-5472

sensitize ovarian cancer cells to alkylating agent temozolomide. *Molecular* 

lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein. *Journal of Biological Chemistry*,

cross-linked DNA v. cross-linking effect caused by local stabilization of the double helix. *Journal of Biomolecular Structure & Dynamics*, Vol.20, No.4, (February 2003),

activated but not constitutive transcription. *Cancer Research*, Vol.62, No. 12, (June

Temozolomide and Status of the DNA-Repair Gene MGMT. *Anticancer Research*,

specificity for antitumor ecteinascidin 743 through protein-DNA interactions? *Journal of Medicinal Chemistry*, Vol.43, No.23, (November 2000), pp. 4367-9, ISSN

F.; Koch, M.; Pfeiffer, B.; Atassi, G.; Hickman, J. & Pierré, A. (2001). Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors. *Clinical Cancer Research*, Vol.7, No.8, (August 2001), pp. 2573-

dependence and higher reactivity for platination of the hairpin r(CGCGUUGUUCGCG) compared with d(CGCGTTGTTCGCG). J*ournal of Biological Inorganic Chemistry*, Vol.11, No.8, (November 2006), pp. 974-90, ISSN 0949-

Zorbas, H.; Dyson, P.J. & Keppler, B.K. (2008). KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients. *Chemistry and Biodiversity*, Vol.5, No.10, (October 2008), pp. 2140-55,

mechanism for B↔Z transition. *Nucleic Acids Research*, Vol.11, No.14, (July 1983),

between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. *Cancer Research*, Vol.66, No.16,


DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair 119

Maillard, O.; Solyom, S. & Naegeli H. (2007). An aromatic sensor with aversion to damaged

Malina, J.; Novakova, O.; Vojtiskova, M.; Natile, G. & Brabec, V. (2007). Conformation of

Malinge, J.M.; Pérez, C. & Leng, M. (1994). Base sequence-independent distorsions induced

*DNA Repair (Amst)*, Vol.7, No.8, (August 2008), pp. 1399-406, ISSN 1568-7864 McCormack; A.I.; McDonald, K.L.; Gill, A.J.; Clark, S.J.; Burt, M.G.; Campbell, K.A.; Braund,

Mendes, F.; Groessl, M.; Nazarov, A.A.; Tsybin, Y.O.; Sava, G.; Santos, I.; Dyson, P.J. &

Mirzoeva O.K.; Kawaguchi, T. & Pieper, R.O. (2006). The Mre11/Rad50/Nbs1 complex

Mocquet, V.; Kropachev, K.; Kolbanovskiy, M.; Kolbanovskiy, A.; Tapias, A.; Cai, Y.;

Moldovan, G.L. & D'Andrea, A.D. (2009). How the fanconi anemia pathway guards the genome. *Annual Review of Genetic*, Vol.43, pp. 223-49, ISSN 0066-4197 Mura, C. & McCammon, J.A. (2008). Molecular dynamics of a kappaB DNA element: base

Narayanan, N.; Gorelick, R.J & DeStefano, J.J. (2006). Structure/function mapping of amino

Vol.71, No.2, (August 2009), pp 226-33, ISSN 0300-0664

(November 2006), pp. 2757-66, ISSN 1535-7163

Vol.26, No.12, (June 2007), pp. 2923-32, ISSN 0261-4189

pp. 2196–206, ISSN 0022-2623

669-78, ISSN 0006-2960

e79, ISSN 1544-9173

3495

strands confers versatility to DNA repair. *PLoS Biology*, Vol.5, No.4, (April 2007),

DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog. *Biophysical Journal*, Vol.93, No.11, (December 2007), pp. 3950-62, ISSN 0006-

by interstrand cross-links in *cis-*diamminedichloroplatinum (II)-modified DNA. *Nucleic Acids Research*, Vol.22, No.19, (September 1994), pp. 3834-9, ISSN 0305-1048 Maor-Shoshani, A.; Meira, L.B.; Yang, X. & Samson, L.D. (2008). 3-Methyladenine DNA

glycosylase is important for cellular resistance to psoralen interstrand cross-links.

W.J.; Little, N.S.; Cook, R.J.; Grossman, A.B.; Robinson, B.G. & Clifton-Bligh, RJ. (2009). Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours. *Clinical Endocrinology*,

Casini, A. (2011). Metal-Based Inhibition of Poly(ADP-ribose) Polymerase - The Guardian Angel of DNA. *Journal of Medicinal Chemistry*, Vol.54, No.7, (March 2011),

interacts with the mismatch repair system and contributes to temozolomideinduced G2 arrest and cytotoxicity. *Molecular Cancer Therapeutics*, Vol.5, No.11,

Broyde, S.; Geacintov, N.E. & Egly, J.M. (2007). The human DNA repair factor XPC-HR23B distinguishes stereoisomeric benzo[*a*]pyrenyl-DNA lesions. *EMBO Journal*,

flipping via cross-strand intercalative stacking in a microsecond-scale simulation. *Nucleic Acids Research*, Vol.36, No.15, (September 2008), pp. 4941-55, ISSN 0305-1048

acids in the N-terminal zinc finger of the human immunodeficiency virus type 1 nucleocapsid protein: residues responsible for nucleic acid helix destabilizing activity. *Biochemistry*, Vol.45, No.41, (October 2006), pp. 12617-28, ISSN 0006-2960 Neher, T.M.; Rechkunova, N.I.; Lavrik, O.I. & Turchi, J.J. (2010). Photo-cross-linking of XPC-

Rad23B to cisplatin-damaged DNA reveals contacts with both strands of the DNA duplex and spans the DNA adduct. *Biochemistry*, Vol.49, No.4, (February 2010), pp.

estrogen metabolite 4-hydroxyequilenin. *Chemical Research in Toxicology,* Vol.18, No.11, (November 2005), pp. 1737-47, ISSN 0893-228X


Kondo, N.; Takahashi, A.; Mori, E.; Noda, T.; Zdzienicka, M.Z.; Thompson, L.H.; Helleday,

Kostrhunova, H.; Vrana, O.; Suchankova, T.; Gibson, D.; Kasparkova, J. & Brabec, V. (2010).

Krueger, A.; Protozanova, E. & Frank-Kamenetskii, M.D. (2006). Sequence-dependent base

Lai, T.C.; Chow, K.C.; Fang, H.Y.; Cho, H.C.; Chen, C.Y.; Lin, T.Y.; Chiang, I.P. & Ho, S.P.

Lange, S.S.; Reddy, M.C. & Vasquez K.M. (2009). Human HMGB1 directly facilitates

Lanuszewska, J. & Widlak, P. (2000). High mobility group 1 and 2 proteins bind

Léonce, S.; Kraus-Berthier, L.; Golsteyn, R.; David-Cordonnier, M.-H.; Tardy, C.; Lansiaux,

Liu, L.; Taverna, P.; Whitacre CM, Chatterjee S. & Gerson S.L. (1999). Pharmacologic

Lum, B. L.; Srinivas, S.; Beck, J. T.; Vesole, D.; Largey, M.; Valone, F. H. & Sayre P. H. (2003).

Macé-Aimé, G.; Couvé, S.; Khassenov, B.; Rosselli, F. & Saparbaev, M.K. (2010). The Fanconi

*Research*, Vol.66, No.14, (July 2006), pp. 7203-10, ISSN 0008-5472

No.11, (November 2005), pp. 1737-47, ISSN 0893-228X

Vol.25, No.5, (May 2011), pp. 1243-51, ISSN 1021-335X

(September 2000), pp. 17–25, ISSN 0304-3835

No.10, (October 1999), pp 2908-17, ISSN 1078-0432

6203

0893-228X

3091-9, ISSN 0006-3495

865-72, ISSN 1568-7864

abstr 943, ISSN 1081-0641

pp. 508-19, ISSN 0893-6692

estrogen metabolite 4-hydroxyequilenin. *Chemical Research in Toxicology,* Vol.18,

T.; Suzuki, M.; Kinashi, Y.; Masunaga, S.; Ono, K.; Hasegawa, M. & Ohnishi, T. (2011). FANCD1/BRCA2 plays predominant role in the repair of DNA damage induced by ACNU or TMZ. *PLoS One*, Vol.6, No5, (May 2011), e19659, ISSN 1932-

Different features of the DNA binding mode of antitumor *cis*amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro. *Chemical Research in Toxicology,* Vol.23, No.11, (November 2010), pp. 1833–42, ISSN

pair opening in DNA double helix. *Biophysical Journal*, Vol.90, No.9, (May 2006), pp.

(2011). Expression of xeroderma pigmentosum complementation group C protein predicts cisplatin resistance in lung adenocarcinoma patients. *Oncology Report*,

interactions between nucleotide excision repair proteins on triplex-directed psoralen interstrand crosslinks. *DNA Repair (Amst)*, Vol.8, No.7, (July 2009), pp.

preferentially to DNA that contains bulky adducts induced by benzo[*a*]pyrene diol epoxide and N-acetoxy-acetylaminofluorene. *Cancer Letters*, Vol.158, No.1,

A.; Poindessous, V.; Larsen, A. K. & Pierré, A. (2006). Generation of replicationdependent double-strand breaks by the novel N2-G-alkylator S23906-1. *Cancer* 

disruption of base excision repair sensitizes mismatch repair-deficient and proficient colon cancer cells to methylating agents. *Clinical Cancer Research*, Vol.5,

Phase I trial of oral gallium maltolate in refractory malignancies. 2003 ASCO Annual Meeting. *Proceedings - American Society of Clinical Oncology Program*, Vol.22,

anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks. *Environmental and Molecular Mutagenesis*, Vol.15, No.6, (July 2010),


DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair 121

Rodríguez, F.A.; Cai, Y.; Lin, C.; Tang, Y.; Kolbanovskiy, A.; Amin, S.; Patel, D.J.; Broyde, S.

Rossouw, J.E.; Anderson, G.L.; Prentice, R.L.; LaCroix, A.Z.; Kooperberg, C.; Stefanick, M.L.;

Schneider, T.D. (2001). Strong minor groove base conservation in sequence logos implies

Schwartz, A.; Marrot, L. & Leng, M. (1989). Conformation of DNA modified at a d(GG) or a

Sharma, A.; Ramanjaneyulu, A.; Ray, R. & Rajeswari, M.R. (2009). Involvement of high

Slama-Schwok, A.; Peronnet, F.; Hantz-Brachete, E.; Taillandier, E.; Teulade-Fichou, M.P.;

Soares, D.G.; Escargueil, A.E.; Poindessous, V.; Sarasin, A.; de Gramont, A.; Bonatto, D.;

Sundheim, O.; Talstad, V.A.; Vågbø, C.B.; Slupphaug, G. & Krokan, H.E. (2008). AlkB

Takahashi, M.; Koi, M.; Balaguer, F.; Boland, C.R. & Goel, A. (2011). MSH3 mediates

*Acids Research*, Vol.25, No.13, (July 1997), pp. 2574-81, ISSN 0305-1048 Soares, D.G.; Battistella, A.; Rocca, C.J.; Matuo, R.; Henriques, J.A.; Larsen, A.K. &

No.3, (July 2002), pp. 321–33, ISSN 0002-9955

(August 2007), pp. 13062-7; ISSN 0027-8424

(November 2008), pp. 1916-23, ISSN 1568-7864

2011), pp. 12157-65, ISSN 0021-9258

Vol.28. No.20, (October 1989), pp. 7975-9, ISSN 0006-2960

1048

1044-5498

ISSN 0264-6021

& Geacintov, N.E. (2007). Exocyclic amino groups of flanking guanines govern sequence-dependent adduct conformations and local structural distortions for minor groove-aligned benzo[*a*]pyrenyl-guanine lesions in a GG mutation hotspot context. *Nucleic Acids Research*, Vol.35, No.5, (March 2007), pp. 1555-68, ISSN 0305-

Jackson, R.D.; Beresford, S.A.; Howard, B.V.; Johnson, K.C.; Kotchen, J.M. & Ockene, J. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women′s Health Initiative randomized controlled trial. *Journal of the American Medical Association*, Vol.288,

DNA distortion or base flipping during replication and transcription initiation. *Nucleic Acids Research*, Vol.29, No.23, (December 2001), pp. 4881-91, ISSN 0305-1048

d(AG) site by the antitumor drug *cis-*diamminedichloroplatinum(II). *Biochemistry*,

mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin. *DNA and Cell Biology*, Vol.28, No.7, (July 2009), pp. 311-8, ISSN

Vigneron, J.P.; Baudoin, O.; Best-Belpomme, M. & Lehn J.M. (1997). A macrocyclic bis-acridine shifts the equilibrium from duplexes towards DNA hairpins. *Nucleic* 

Escargueil, A.E. (2011). Ataxia telangiectasia mutated- and Rad3-related kinase drives both the early and the late DNA-damage response to the monofunctional antitumour alkylator S23906. *Biochemical Journal*, Vol.47, No.1, (July 2011), pp. 63-73,

Henriques, J.A. & Larsen A.K. (2007). Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. *Proceedings of the National Academy of Sciences USA*, Vol.104, No32,

demethylases flip out in different ways. *DNA Repair (Amst)*, Vol.7, No. 11,

sensitization of colorectal cancer cells to cisplatin, oxaliplatin and a poly(ADPribose) polymerase inhibitor. *Journal of Biological Chemistry*, Vol.286, No.14, (April


Newlands, E.S.; Stevens, M.F.G.; Wedge, S.R.; Wheelhouse, R.T. & Brock C. (1997).

Notch, E.G. Miniutti, D.M. & Mayer, G.D. (2007). 17alpha-Ethinylestradiol decreases

Nováková, O.; Nazarov, A.A.; Hartinger, C.G.; Keppler, B.K. & Brabec, V. (2009). DNA

Nováková, O.; Malina, J.; Suchankova, T.; Kasparkova, J.; Bugarcic, T.; Sadler, P.J. & Brabec,

Park, S. & Lippard, S.J. (2011). Redox state-dependent interaction of HMGB1 and cisplatin-

Pisha, E.; Lui, X.; Constantinou, A. I. & Bolton, J. L. (2001). Evidence that a metabolite of

Planck, S.R. & Wilson, S.H. (1980). Studies on the structure of mouse helix-destabilizing

*Chemistry*, Vol.255, No.23, (December 1980), pp. 11547-56, ISSN 0021-9258 Pommier, Y.; Kohlhagen, G.; Bailly, C.; Waring, M.J.; Mazumder, A. & Kohn, K.W. (1996).

Privalov, P.L.; Dragan, A.I. & Crane-Robinson, C. (2009). The cost of DNA bending. *Trends in Biochemical Sciences*, Vol.34, No.9, (September 2009), pp. 464-70, ISSN 0968-0004 Putnam, B.F.; Van Zandt, L.L.; Prohofsky, E.W. & Mei, W.N. (1981). Resonant and localized

Rocca, C.J.; Poindessous, V.; Soares, D.G.; Ouadrani, K.E.; Sarasin, A.; Guérin, E.; de

Vol.35, No.2, (August 1981), pp. 271-87, ISSN 0006-3495

No.19, (May 2010), pp. 5744-54, ISSN 1521-3765

1997), pp 35–61, ISSN 0305-7372

5521

2960

228X

13303-9, ISSN 0006-2960

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. *Cancer Treatment Reviews*, Vol.23, No.1, (January

expression of multiple hepatic nucleotide excision repair genes in zebrafish (Danio rerio). *Aquatic Toxicology*, Vol.84, No.3, (October 2007), pp. 301-9, ISSN 0166-445X Nováková, O.; Kasparkova, J.; Bursova, V.; Hofr, C.; Vojtiskova, M.; Chen, H.; Sadler, P.J. &

Brabec, V. (2005). Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity. *Chemistry & Biology*, Vol.12, No.1, (January 2005), pp. 121-9, ISSN 1074-

interactions of dinuclear RuII arene antitumor complexes in cell-free media. *Biochemical Pharmacology*, Vol.77, No.3, (February 2009), pp. 364-74, ISSN 0006-2952

V. (2010). Energetics, conformation, and recognition of DNA duplexes modified by monodentate Ru(II) complexes containing terphenyl arenes. *Chemistry*, Vol.16,

modified DNA. *Biochemistry*, Vol.50, No.13, (April 2011), pp. 2567-74, ISSN 0006-

equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. *Chemical Research in Toxicology,* Vol.14, No.1, (January 2001), pp. 82–90, ISSN 0893-

protein-1. DNA binding and controlled proteolysis with trypsin. *Journal of Biological* 

DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. *Biochemistry*, Vol.35, No.41, (October 1996), pp.

breathing modes in terminal regions of the DNA double helix. *Biophysical Journal*,

Gramont, A.; Henriques, J.A.; Escargueil, A.E. & Larsen, A.K. (2010). The NER proteins XPC and CSB, but not ERCC1, regulate the sensitivity to the novel DNA binder S23906: Implications for recognition and repair of antitumor alkylators. *Biochemical Pharmacology*, Vol.80, No.3, (August 2010), pp. 335-43, ISSN 0006-2952


DNA Helix Destabilization by Alkylating Agents: From Covalent Bonding to DNA Repair 123

Vasquez, K.M.; Christensen, J.; Li, L.; Finch, R.A. & Glazer, P.M. (2002). Human XPA and

Wold, M.S. (1997). Replication protein A: a heterotrimeric, single-stranded DNA-binding

Wu, M.; Yan, S.; Patel, D.J.; Geacintov, N.E. & Broyde, S. (2002). Relating repair

Wu, Q.; Christensen, L.A.; Legerski, R.J. & Vasquez, K.M. (2005). Mismatch repair

Yang, C.G.; Garcia, K. & He, C. (2009). Damage detection and base flipping in direct DNA

Yang, J.; Liu, X.; Niu, P.; Zou, Y. & Duan, Y. (2009). Correlations and co-localizations of

Yang, W. (2006). Poor base stacking at DNA lesions may initiate recognition by many repair proteins. *DNA Repair (Amst)*, Vol.5, No6, (June 2006), pp. 654-66, ISSN 1568-7864 Yuqin, C.; Dinshaw, J.P.; Nicholas, E.G. & Suse, B. (2009). Differential nucleotide excision

Zhang, C.X. & Lippard, S.J. (2003). New metal complexes as potential therapeutics. *Current Opinion in Chemical Biology*, Vol.7, No.4, (August 2003), pp. 481-9, ISSN 1367-5931 Zhang, J.; Stevens, M.F.; Laughton, C.A.; Madhusudan, S. & Bradshaw, T.D. (2010).

Zhang, Y.; Rohde, L.H. & Wu, H. (2009). Involvement of nucleotide excision and mismatch

Zhao, J.; Jain, A.; Iyer, R.R.; Modrich, P.L. & Vasquez, K.M. (2009). Mismatch repair and

EMBO Reports, Vol.6, No.6, (June 2005), pp. 551–7, ISSN 1469-221X. Wu, Q & Vasquez, K.M. (2008). Human MLH1 protein participates in genomic damage

(April 2002), pp. 5848–53, ISSN 0027-8424

Vol.66, (July 1997), pp. 61-92, ISSN 1545-4509

(January 2009), pp. 30-44, ISSN 0022-2836

(June 2009), pp 250–8, ISSN 1389-2029

103-14, ISSN 0030-2414

3422-32, ISSN 0305-1048

ISSN 1553-7390

1439-4227

483X

1048

RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. *Proceedings of the National Academy of Sciences USA*, Vol.99, No.9,

protein required for eukaryotic DNA metabolism. *Annual Review of Biochemistry*,

susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability. *Nucleic Acids Research*, Vol.30, No.15, (August 2002), pp.

participates in error-free processing of DNA interstrand crosslinks in human cells.

checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repair. PLoS Genetics, Vol.4, No.9 (September 2008), e1000189,

alkylation repair. *Chembiochem*, Vol.10, No.3, (February 2009), pp. 417-423, ISSN

Hsp70 with XPA, XPG in human bronchial epithelia cells exposed to benzo[*a*]pyrene. *Toxicology*, Vol. 265, No.1-2, (November 2009), pp. 10-4, ISSN 0300-

repair susceptibility of bulky DNA adducts in different sequence contexts: Hierarchies of recognition signals. *Journal of Molecular Biology*, Vol.385, No.1,

Acquired resistance to temozolomide in glioma cell lines: molecular mechanisms and potential translational applications. *Oncology*. Vol.78, No.2, (March 2010), pp

repair mechanisms in double strand break repair. *Current Genomics*, Vol.10, No.4,

nucleotide excision repair proteins cooperate in the recognition of DNA interstrand crosslinks. *Nucleic Acids Research*, Vol.37, No.13, (July 2009), pp. 4420-9, ISSN 0305-


Takebayashi, Y.; Pourquier, P.; Zimonjic, D.B.; Nakayama, K.; Emmert, S.; Ueda, T.; Urasaki,

Tang, J.B.; Svilar, D.; Trivedi, R.N.; Wang, X.H.; Goellner, E.M.; Moore, B.; Hamilton, R.L.;

Teulade-Fichou, M.P; Vigneron, J.P & Lehn, J.M. (1995). Molecular recognition of

Thoma, B.S.; Wakasugi, M.; Christensen, J.; Reddy, M.C. & Vasquez, K.M. (2005). Human

Todd, R.C. & Lippard S.J. (2010). Structure of duplex DNA containing the cisplatin 1,2-

Triantafillidi, K.; Karidi, K.; Novakova., O; Malina, J. & Garoufis, A. (2011). DNA binding

Trimmer, E.E.; Zamble, D.B.; Lippard, S.J. & Essigmann, J.M. (1998). Human testis-

Trivedi, R.N.; Wang X.; Jelezcova, E.; Goellner, E.M.; Tang, J. & Sobol R.W. (2008). Human

Tubbs, J.L.; Pegg, A.E. & Tainer, J.A. (2007). DNA binding, nucleotide flipping, and the

*Biochemistry*, Vol.104, No.9, (September 2010), pp. 902-8, ISSN 0162-0134 Treiber, D.K; Zhai, X.; Jantzen, H.M. & Essigmann, J.M. (1994). Cisplatin-DNA adducts are

temozolomide, *Neuro-Oncology*, (April 2011), online, ISSN 1522-8517 Tavecchio, M.; Simone, M.; Erba, E.; Chiolo, I.; Liberi, G.; Foiani, M.; D'Incalci, M. & Damia,

*Discovery and Development*, Beverly A. Teicher Editor.

Vol.91, No.12, (June 1994), pp. 5672-6, ISSN 0027-8424

Vol.40, No.2, (January 2011), pp. 472-83, ISSN 0022-4944

(February 1995), pp. 139-47, ISSN 1061-0278

2005), pp. 2993-3001, ISSN 0305-1048

1998), pp. 352-362, ISSN 0006-2960

2008), pp 505–516, ISSN 0026-895X

2007), pp. 1100-15, ISSN 1568-7864

961-6, ISSN 1078-8956

Y.; Kanzaki, A.; Akiyama, S.I.; Popescu, N.; Kraemer, K.H. & Pommier, Y. (2001). Antiproliferative activity of ecteinascidin 743 is dependent upon transcriptioncoupled nucleotide-excision repair. *Nature Medicine*, Vol.7,No.8, (August 2001), pp.

Banze, L.A.; Brown, A.R. & Sobol, R.W. (2011). N-methylpurine DNA glycosylase and DNA polymerase {beta} modulate BER inhibitor potentiation of glioma cells to

G. (2008). Role of homologous recombination in trabectedin-induced DNA damage. *European Journal of Cancer*, Vol.44, No4, (March 2008), pp. 609-18, ISSN 1359-6349 Teicher, BA. (1996). Cancer therapeutics: Experimental and clinical agents. *Cancer Drug* 

nucleosides and nucleotides by a water soluble cyclo-bis-intercaland type receptor molecule based on acridine subunits. *Supramolecular Chemistry*, Vol.5, No.2,

XPC-hHR23B interacts with XPA-RPA in the recognition of triplex-directed psoralen DNA interstrand crosslinks. *Nucleic Acids Research*, Vol.33, No.9, (May

{Pt(NH3)2}2+-d(GpG) cross-link at 1.77 A resolution. *Journal of Inorganic* 

molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). *Proceedings of the National Academy of Sciences USA*,

selectivity of oligopyridine-ruthenium(II)-lysine conjugate. *Dalton Transactions*,

determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities. *Biochemistry*, Vol.37, No.1, (January

methyl purine DNA glycosylase and DNA polymerase β expression collectively predict sensitivity to Temozolomide. *Molecular Pharmacology*, Vol.74, No.2, (August

helix-turn-helix motif in base repair by O6-alkylguanine-DNA alkyltransferase and its implications for cancer chemotherapy. *DNA Repair (Amst)*, Vol.6, No8, (August


**6** 

*México* 

**DNA Damage Caused by Polycyclic Aromatic** 

Polycyclic Aromatic Hydrocarbons (PAHs) are a group of chemicals that occur naturally in coal, crude oil and gasoline. Incomplete combustion of organic material results in emission of PAHs (ATSDR, 1996). These molecules consist of two or more aromatic rings fused in linear, angular or cluster arrangements (Fig. 1) and by definition are composed of hydrogen and carbon. PAHs containing up to six fused aromatic rings are often known as "small" PAHs while those containing more than six aromatic rings are called "large" PAHs. As pure chemicals, these compounds are colorless, white or pale yellow solids. Their physicochemical properties, vapor pressure and solubility vary according to their molecular weight. PAHs possess a highly characteristic UV absorbance spectra although some may be fluorescent (Fetzer & Biggs, 1994). PAHs are ubiquitous and persistent as a consequence of natural (forest fires and volcanic eruptions) and human activities (Jongeneelen, 2001). PAHs may distribute in water, soil and the atmosphere according to different weather and geographical factors. Although industrial activity such as coke manufacturing or asphalt production are major contributors to PAH emissions, incineration, power generation and several mobile sources also emit a considerable amount of PAHs. Significant sources of PAHs in surface waters include deposition of airborne PAHs, municipal wastewater discharge, urban storm-water runoff, and industrial waste. Food groups that tend to have the highest levels of PAHs include charcoal broiled or smoked meats, leafy vegetables, grains, and vegetable fats and oils (Yu, 2005). Therefore, workers of these industries and the general population are continually exposed to different concentrations of PAH mixtures. The Agency for Toxic Substances and Disease Registry (ATSDR) has grouped 17 PAHs according to their health effects (ATSDR, 1996). The United States Environmental Protection Agency (EPA) has designated 28 PAH compounds as priority pollutants (EPA, 2009) (Table 1). The International Agency for Research on Cancer (IARC) has classified some these compounds as carcinogenic (group 1) or likely carcinogenic (group 2A) to humans, for example benzo[*a*]pyrene and dibenz[*a,h*]anthracene, respectively (IARC, 2010). Finally, the National Institute of Standards and Technology has created a classification of PAHs according to their symbols, molecular formulas, class and notation among other properties

The most common mechanism of carcinogenesis induced by PAHs is DNA damage through the formation of adducts. Alternatively, in the presence of reactive oxidative species, DNA

**1. Introduction** 

(NIST, 2010).

**Hydrocarbons: Mechanisms and Markers** 

Balam Muñoz and Arnulfo Albores

*Centro de Investigación y de Estudios Avanzados del I.P.N.* 

*Departamento de Toxicología,* 

